Teva Pharmaceutical-Sp

TEVA(Teva Pharmaceutical-Sp)

$39.00-0.33%

TEVA(Teva Pharmaceutical-Sp) Price Prediction Summary

AI-Generated
As of September 19, 2026, TEVA is currently trading in an uptrend, with price firmly above its 20-, 50-, and 200-day moving averages and MACD momentum positive. The technical setup favors continuation, though RSI near 62 signals caution against overextension—pullback risk lingers if sentiment turns or resistance is tested. Key uncertainty remains the sustainability of this move and whether overbought conditions will trigger near-term consolidation. Watch the 37.44 level \(20-SMA\) for support and any RSI divergence as early reversal signals.
Technical Indicators
Short-Term Bullish

Daily chart shows sustained uptrend with price above all key moving averages and positive MACD confirmation.

Key Trading Levels

How Gate Predicts TEVA(Teva Pharmaceutical-Sp) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of September 19, 2026, **TEVA technical analysis** confirms a bullish intermediate setup. The stock trades above its 20-day SMA \(37.44\), 50-day SMA \(35.35\), and 200-day SMA \(33.15\), with each successive level offering support — a textbook bullish alignment. MACD at 0.849 sits firmly in positive territory, validating the uptrend\'s momentum. RSI at 62.21 reflects overbought conditions creeping in but not yet at extremes \(>70\), suggesting room for further consolidation or modest continuation before pullback risk rises. The moving average stack — short, intermediate, and long-term — all lean bullish, indicating conviction across multiple timeframes. Near-term TEVA price forecast hinges on whether the RSI overbought signal triggers profit-taking or if momentum persists; watch the daily close relative to the 20-SMA at 37.44 as the first line of support if selling pressure emerges.
IndicatorValueSignal
Exponential Moving Average (10)38.1488
Buy
Exponential Moving Average (100)34.7104
Buy
Exponential Moving Average (20)37.4798
Buy
Exponential Moving Average (200)32.0743
Buy
Exponential Moving Average (30)36.937
Buy
Exponential Moving Average (50)36.1086
Buy
Hull Moving Average (9)39.5544
Sell
Ichimoku Base Line (9, 26, 52, 26)37.56
neutral
Moving Averages Summary
neutral
Simple Moving Average (10)37.808
Buy
Simple Moving Average (100)34.7943
Buy
Simple Moving Average (20)37.439
Buy
Simple Moving Average (200)33.146
Buy
Simple Moving Average (30)37.137
Buy
Simple Moving Average (50)35.3532
Buy
Volume Weighted Moving Average (20)37.5343
Buy
Average Directional Index (14)32.7744
neutral
Awesome Oscillator2.0495
neutral
Bull Bear Power2.1982
neutral
Commodity Channel Index (20)127.3261
Sell
MACD Level (12, 26)0.849
Buy
Momentum (10)2.36
Buy
Oscillators Summary
neutral
Relative Strength Index (14)62.2086
neutral
Stochastic %K (14, 3, 3)82.3718
Sell
Stochastic RSI Fast (3, 3, 14, 14)73.401
neutral
Ultimate Oscillator (7, 14, 28)61.0348
neutral
Williams Percent Range (14)-16.8224
Sell
Technical Summary
neutral

Market Sentiment

AI-GeneratedNo data yet
Analyst Rating
--
Options Put/Call Ratio
77.0100%
Implied Volatility (IV)
13.1969

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

TEVA(Teva Pharmaceutical-Sp) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

How are technical indicators used in the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

What role does market sentiment play in the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

What common factors can influence the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

How can price predictions be used to assess the current market state of TEVA(Teva Pharmaceutical-Sp)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.